Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis

Cancer Genetics and Cytogenetics

Volumn 177, Issue 1, 2007, Pages 16-19

  Armengol, Gemma ^a,b   Eissa, Saad ^c   Lozano, Juan José ^d   Shoman, Sohair ^c   Sumoy, Lauro ^d   Caballín, María Rosa ^a   Knuutila, Sakari ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL CANCER INSTITUTE   (Egypt)

^d CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CHROMOSOME 11Q; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MICROARRAY; ENDEMIC DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS;

CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; HUMANS; KARYOTYPING; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCHISTOSOMIASIS HAEMATOBIA; URINARY BLADDER NEOPLASMS;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

EID: 34547744399     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.04.010     Document Type: Article

References (27)

1. Badawi A.F. Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 105 (1996) 123-138
2. Johansson S.L., and Cohen S.M. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13 (1997) 291-298
3. Warren W., Biggs P.J., el-Baz M., Ghoneim M.A., Stratton M.R., and Venitt S. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 16 (1995) 1181-1189
4. Ghaleb A.H., Pizzolo J.G., and Melamed M.R. Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization. Am J Clin Pathol 106 (1996) 234-241
5. Pycha A., Mian C., Posch B., Haitel A., El-Baz M., Ghoneim M.A., and Marberger M. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization. J Urol 160 (1998) 737-740
6. Muscheck M., Abol-Enein H., Chew K., Moore II D., Bhargava V., Ghoneim M.A., Carroll P.R., and Waldman F.M. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 21 (2000) 1721-1726
7. Fadl-Elmula I., Kytola S., Leithy M.E., Abdel-Hameed M., Mandahl N., Elagib A., Ibrahim M., Larsson C., and Heim S. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2 (2002) 5
8. El-Rifai W., Kamel D., Larramendy M.L., Shoman S., Gad Y., Baithun S., El-Awady M., Eissa S., Khaled H., Soloneski S., Sheaff M., and Knuutila S. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. Am J Pathol 156 (2000) 871-878
9. Albertson D.G., and Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12 (2003) R145-R152
10. Mostofi F.K., Sobin L.H., and Torloni H. Histological typing of urinary bladder tumours. International Histological Classification of Tumours (1973), World Health Organization, Geneva
11. Atiye J., Wolf M., Kaur S., Monni O., Bohling T., Kivioja A., Tas E., Serra M., Tarkkanen M., and Knuutila S. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosom Cancer 42 (2005) 158-163
12. University of California. Santa Cruz's Genome Browser database. Available at: http://www.genome.ucsc.edu/ Accessed March, 2006.
13. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74 (1979) 829-836
14. Olshen A.B., and Venkatraman E.S. Change-point analysis of array-based comparative genomic hybridization data. American Statistical Association Proceedings of the Joint Statistical Meetings (2002) 2530-2535
15. Kendziorski C., Irizarry R.A., Chen K.S., Haag J.D., and Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 102 (2005) 4252-4257
16. Blaveri E., Brewer J.L., Roydasgupta R., Fridlyand J., DeVries S., Koppie T., Pejavar S., Mehta K., Carroll P., Simko J.P., and Waldman F.M. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11 (2005) 7012-7022
17. Veltman J.A., Fridlyand J., Pejavar S., Olshen A.B., Korkola J.E., DeVries S., Carroll P., Kuo W.L., Pinkel D., Albertson D., Cordon-Cardo C., Jain A.N., and Waldman F.M. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63 (2003) 2872-2880
18. Hurst C.D., Fiegler H., Carr P., Williams S., Carter N.P., and Knowles M.A. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23 (2004) 2250-2263
19. Krishnan R., and Cleary E.G. Elastin gene expression in elastotic human breast cancers and epithelial cell lines. Cancer Res 50 (1990) 2164-2171
20. Luo Z., Saha A.K., Xiang X., and Ruderman N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26 (2005) 69-76
21. Pasqualucci L., Compagno M., Houldsworth J., Monti S., Grunn A., Nandula S.V., Aster J.C., Murty V.V., Shipp M.A., and Dalla-Favera R. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203 (2006) 311-317
22. Deng Q., and Huang S. PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene 23 (2004) 4903-4910
23. Yang X.H., and Huang S. PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1. Genomics 61 (1999) 319-325
24. Ishizawar R., and Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 6 (2004) 209-214
25. Sankpal N.V., Moskaluk C.A., Hampton G.M., and Powell S.M. Overexpression of CEBPbeta correlates with decreased TFF1 in gastric cancer. Oncogene 25 (2006) 643-649
26. Homma J., Yamanaka R., Yajima N., Tsuchiya N., Genkai N., Sano M., and Tanaka R. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol Rep 15 (2006) 595-601
27. Li S., Huang S., and Peng S.B. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol 27 (2005) 1329-1339